In vitro effects of the platelet glycoprotein IIb/IIIa receptor antagonists c7E3 fab on the activated clotting time - Response

被引：0
|
作者：
Amar, T
Coller, BS
机构：
来源：
CIRCULATION | 1997年 / 96卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3794 / 3794
页数：1
相关论文
共 50 条
  • [1] In vitro effects of the platelet glycoprotein IIb/IIIa receptor antagonists c7E3 fab on the activated clotting time
    Levy, JH
    Kelley, A
    CIRCULATION, 1997, 96 (10) : 3793 - 3794
  • [2] In vitro effects of the platelet glycoprotein IIb/IIIa receptor antagonist c7E3 Fab on the activated clotting time
    Ammar, T
    Scudder, LE
    Coller, BS
    CIRCULATION, 1997, 95 (03) : 614 - 617
  • [3] ACTIVATED CLOTTING TIME OF HEPARINIZED BLOOD IS INCREASED BY IN-VITRO PLATELET GLYCOPROTEIN IIB/IIIA RECEPTOR BLOCKADE WITH ANTIBODY C7E3 FAB
    AMMAR, T
    SARIER, K
    COLLER, BS
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1313 - 1313
  • [4] Effects of the glycoprotein IIb/IIIa receptor antagonist c7E3 Fab and anticoagulants on platelet aggregation and thrombin potential under high coagulant challenge in vitro
    Koestenberger, M
    Gallistl, S
    Cvirn, G
    Roschitz, B
    Muntean, W
    BLOOD COAGULATION & FIBRINOLYSIS, 2000, 11 (05) : 425 - 432
  • [5] Evidence for a decreased thrombin generation after platelet glycoprotein IIb/IIIa receptor antagonist c7E3 FAB infusion.
    Musso, R
    Cabibbo, S
    Cultrera, D
    Russo, M
    Russo, G
    Nicosia, A
    Mammana, C
    Tamburino, C
    Giustolisi, R
    BLOOD, 1997, 90 (10) : 1321 - 1321
  • [6] Glycoprotein IIb/IIIa receptor antagonist c7E3 fab and anticoagulants show an additive effect on thrombin-induced platelet aggregation after high coagulant challenge in vitro
    Köstenberger, M
    Gallistl, S
    Cvirn, G
    Roschitz, B
    Muntean, W
    30TH HEMOPHILIA SYMPOSIUM, 2001, : 369 - 377
  • [7] Effects of GP IIb/IIIa receptor antagonists on the activated clotting time of heparinized blood
    Himber, J
    Burcklen, L
    Steiner, B
    BLOOD, 2000, 95 (06) : 2189 - 2190
  • [8] Concept and clinical application of platelet glycoprotein IIb/IIIa inhibition with abciximab (c7E3 fab; ReoPro) for the prevention of acute ischemic syndromes
    Anderson, HV
    Jordan, RE
    Weisman, HF
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 1997, 3 (04) : 256 - 266
  • [9] Sudden onset of EDTA-dependent pseudothrombocytopenia after therapy with the glycoprotein IIb/IIIa antagonist c7E3 Fab
    H. Stiegler
    Y. Fischer
    S. Steiner
    B. E. Strauer
    H. Reinauer
    Annals of Hematology, 2000, 79 : 161 - 164
  • [10] Sudden onset of EDTA-dependent pseudothrombocytopenia after therapy with the glycoprotein IIb/IIIa antagonist c7E3 Fab
    Stiegler, H
    Fischer, Y
    Steiner, S
    Strauer, BE
    Reinauer, H
    ANNALS OF HEMATOLOGY, 2000, 79 (03) : 161 - 164
12345